Colorectal cancer screening tests: pros and cons, and for whom?
The past decade has seen major advances internationally in the implementation of colorectal cancer screening, influenced in differing ways by the profession, the public and by government. Relatively unique to colorectal cancer screening is the availability of so many test alternatives, which have substantial variation in methodology. While perhaps spoilt for choice, discerning the key advantages and disadvantages of each test is often difficult, depending on the perspective from which screening is viewed. Accordingly, this article provides an evaluation of screening tests as might be perceived by governments, the patient and the profession. Aligned issues such as choosing a screening test and provision of informed consent are discussed. Finally, the article identifies current problems with various screening tests that, if attended to, might change the perception of a test's value to a particular interest group.
Forbes
Geoffrey M
GM
Department of Gastroenterology and Hepatology, Royal Perth Hospital, Box X2213 GPO, Perth, Western Australia 6000, Australia. geoff.forbes@health.wa.gov.au
D015179:Colorectal Neoplasms / Q000175:diagnosis*; D006801:Humans; D008403:Mass Screening / Q000379:methods* / Q000639:trends*; D017410:Practice Guidelines as Topic